leadf
logo-loader
ASX:CDX

CardieX Ltd

Receive alerts
Market:
ASX
Market Cap:
$56.49 m
Price
0.06 AUD
Change
-1.61%
52 weeks high
0.12
52 weeks low
0.04

In brief

Cardiex Ltd (ASX:CDX) is a global health technology company focused on hypertension, cardiovascular disease, and other vascular health disorders.

The company’s ATCOR division is the world leader in medical devices for measuring arterial stiffness and central blood pressure waveforms based on its unique FDA-cleared and patented SphygmoCor technology.

The company’s digital platform, ArtyNet, is a connected SaaS ecosystem providing physicians with a complete telehealth solution for remotely managing patients’ health.

Snapshot

  • CardieX expands chronic kidney disease clinical trial agreement with Bayer
  • CardieX rounds off June quarter with strong sales, $3.67 million cash balance
  • CardieX releases first-half results as company achieves 5-year record high revenue

Insight Widest with the analysis, Proactive gives perspectives that others don't.

CardieX rounds off June quarter with strong sales, $3.67 million cash balance

Moving into FY22, CardieX continues to evolve its blood pressure monitor and wearable health tech offering ahead of their transition to market.

on 26/7/21